Rare diseases
Investigational molecules
Locations
Back to France819 clinical trials in Dijon, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
FranceEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
FranceStudy of denikitug alone or in drug combination in adults with advanced microsatellite stable colorectal cancer
FranceEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
FranceA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
FranceFranceA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
FranceA Study of Saruparib for Patients with Metastatic Pancreatic Cancer with Homologous Repair Deficiency as First Treatment
FranceStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
FranceStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
FranceStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for head and neck cancer, gastric cancer, and multiple types of lung cancer. Research encompasses novel therapeutic approaches and targeted treatments.
Several studies are evaluating new combination therapies and immunotherapy approaches for better treatment outcomes.
Research focusing on immune system responses and vaccine development, with particular emphasis on COVID-19 prevention and treatment strategies. Studies include innovative approaches to boosting immunity.
Trials are investigating both intranasal and traditional vaccination methods for optimal immune response.
Studies focusing on heart disease management and prevention, including innovative treatments for acute myocardial infarction and heart failure prevention strategies.
Research includes novel pain management approaches and preventive treatments for cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
